Browse
related articles
Hikma looking to expand beyond Mena
- Jordan: Sunday, October 14 - 2012 at 02:40
Jordan-based Hikma Pharmaceuticals has said it is looking to expand in Africa over the next two to three years, through building its own plant or by making an acquisition of up to $300m, Reuters has reported. "We really want to change from a pure Mena company into an emerging markets company by looking into the rest of Africa and some other markets," Said Darwazah, Hikma's chief executive, told the news service. "Within the next two to three years, we should start making some good inroads into the Africa market."
Related Content
Article Options
Disclaimer »
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by Mediaquest FZ LLC and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
Mediaquest FZ LLC can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of Mediaquest FZ LLC.
In no event shall Mediaquest FZ LLC be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
